Is Krystexxa Covered By Medicare? 
Krystexxa is a medication used to treat gout and can be effective when other treatments have not produced the desired results . FDA approval for Krystexxa was granted in 2010 . In 2011 Medicare assigned a treatment code to Krystexxa . Krystexxa is infusion therapy , covered under Medicare Part B. Due to the cost -LRB- $ 60,000 per year -RRB- there may be limits placed on how many treatments will be approved by Medicare . 